Cited by 31Parkinson's Disease Mechanisms and TreatmentsUbiquitin and proteasome pathwaysAlzheimer's disease research and treatments

Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in PC12D cells

Kawahata, Ichiro, Tokuoka, Hirofumi, Parvez, Hasan, Ichinose, Hiroshi·2009·Journal of Neural Transmission

Abstract

Tyrosine hydroxylase (TH) is a rate-limiting enzyme for the biosynthesis of catecholamines including dopamine. The relationship between proteasomal dysfunction and the etiology of Parkinson's disease has been suggested, but it is unknown if TH protein is affected by proteasomal dysfunctions. Here, we examined the effect of inhibition of ubiquitin-proteasomal pathway on biochemical characteristics of TH protein in the neuronal cells. Inhibition of 20S or 26S proteasome by proteasome inhibitor I, or MG-132 in NGF-differentiated PC12D cells induced dot-like immunoreactivities with the anti-(40)Ser-phosphorylated TH (p40-TH) antibody. These dots were tightly co-localized with ubiquitin and positive to Thioflavine-S staining. These dot-like immunoreactivities were not obvious when immunostaining was performed against total-TH or choline acetyltransferase. Western blotting analysis showed time-dependent increase of p40-TH in the Triton-insoluble fractions. We also examined the effect of okadaic acid, an inhibitor of protein phosphatase 2A, which is a phosphatase acting on p40-TH. Okadaic acid increased the amount of insoluble p40-TH. These data suggest that p40-TH is prone to be insolubilized and aggregated by dysfunction of an ubiquitin-proteasome system in PC12D cells.

Integrity signals

Registry

Crossref · 10.1007/s00702-009-0304-z

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 29 · Cited by 31

Authors
Kawahata, I., Tokuoka, H., Parvez, H., & Ichinose, H.
Affiliations
  • Tokyo Institute of Technology (JP)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Ichinose, Hiroshi
Venue
Journal of Neural Transmission
Published
2009-09-12
Volume
116
Issue
12
Pages
1571-1578
ISSN
  • 0300-9564 (ISSN-L)
  • 1435-1463
OpenAlex
W2013120967
Cited by
31
References
29
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 1 · 2018: 1 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 1 · 2012: 2
FWCI
0.85
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neural Transmission (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
  • Tokyo Tech Research Repository (Tokyo Institute of Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
tyrosine hydroxylase, protein aggregation, ubiquitin-proteasome system, proteasome inhibition, Parkinson's disease, PC12D cells, dopamine synthesis, protein phosphatase 2A, okadaic acid, proteasomal dysfunction
MeSH terms
Animals, Choline O-Acetyltransferase, Enzyme Inhibitors, Leupeptins, Neurons, Oligopeptides, Phosphorylation, Time Factors, Tyrosine 3-Monooxygenase, Cysteine Proteinase Inhibitors, PC12 Cells, Okadaic Acid, Ubiquitin, Proteasome Endopeptidase Complex, Rats, Protein Phosphatase 2, Protein Multimerization, Proteasome Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review